Governing antimicrobial resistance: a narrative review of global governance mechanisms

被引:0
作者
Arne Ruckert
Patrick Fafard
Suzanne Hindmarch
Andrew Morris
Corinne Packer
David Patrick
Scott Weese
Kumanan Wilson
Alex Wong
Ronald Labonté
机构
[1] University of Ottawa,Corinne School of Epidemiology and Public Health
[2] University of Ottawa,Graduate School of Public and International Affairs
[3] University of New Brunswick,Department of Political Science
[4] University of Toronto,Faculty of Medicine
[5] University of British Columbia,School of Population and Public Health
[6] University of Guelph,Department of Pathobiology, Ontario Veterinary College
[7] Ottawa Hospital,Department of Biology
[8] Carleton University,Corinne School of Epidemiology and Public Health
[9] University of Ottawa,undefined
来源
Journal of Public Health Policy | 2020年 / 41卷
关键词
Antimicrobial resistance; Global governance; International law; Health regulations;
D O I
暂无
中图分类号
学科分类号
摘要
Antimicrobial resistance (AMR), a central health challenge of the twenty first century, poses substantial population health risks, with deaths currently estimated to be around 700,000 per year globally. The international community has signaled its commitment to exploring and implementing effective policy responses to AMR, with a Global Action Plan on AMR approved by the World Health Assembly in 2015. Major governance challenges could thwart collective efforts to address AMR, along with limited knowledge about how to design effective global governance mechanisms. To identify common ground for more coordinated global actions we conducted a narrative review to map dominant ideas and academic debates about AMR governance. We found two categories of global governance mechanisms: binding and non-binding and discuss advantages and drawbacks of each. We suggest that a combination of non-binding and binding governance mechanisms supported by leading antimicrobial use countries and important AMR stakeholders, and informed by One Health principles, may be best suited to tackle AMR.
引用
收藏
页码:515 / 528
页数:13
相关论文
共 93 条
[21]  
O’Malley L(2017)Reflections on the future of pharmaceutical public–private partnerships: from input to impact Pharm Res 34 1985-undefined
[22]  
Hoffman SJ(2016)The Innovative Medicines Initiative’s New Drugs for Bad Bugs Programme: European public–private partnerships for the development of new strategies to tackle antibiotic resistance J Antimicrob Chemother 71 290-undefined
[23]  
Behdinan A(2017)An international model for antibiotics regulation Food Drug Law J 72 295-undefined
[24]  
Hoffman SJ(2018)Beyond headline mitigation numbers: we need more transparent and comparable NDCs to achieve the Paris Agreement on Climate Change Clim Change 147 23-undefined
[25]  
Ottersen T(2018)WHO FCTC and global governance: effects and implications for future global public health instruments Tob Control 15 54-undefined
[26]  
Hoffman SJ(2019)The glocalization of antimicrobial stewardship Glob Health undefined undefined-undefined
[27]  
Outterson K(2020)Exploring models for an international legal agreement on the global antimicrobial commons: lessons from climate agreements Health Care Anal undefined undefined-undefined
[28]  
Røttingen J-A(undefined)undefined undefined undefined undefined-undefined
[29]  
Cars O(undefined)undefined undefined undefined undefined-undefined
[30]  
Clift C(undefined)undefined undefined undefined undefined-undefined